SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-22-013834
Filing Date
2022-08-22
Accepted
2022-08-22 08:44:23
Documents
15
Period of Report
2022-08-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K enfn-20220821x8k.htm   iXBRL 8-K 46506
2 EX-10.1 enfn-20220821xex10d1.htm EX-10.1 29865
3 EX-10.2 enfn-20220821xex10d2.htm EX-10.2 54145
4 EX-99.1 enfn-20220821xex99d1.htm EX-99.1 11412
  Complete submission text file 0001558370-22-013834.txt   288932

Data Files

Seq Description Document Type Size
5 EX-101.SCH enfn-20220821.xsd EX-101.SCH 3047
6 EX-101.LAB enfn-20220821_lab.xml EX-101.LAB 16686
7 EX-101.PRE enfn-20220821_pre.xml EX-101.PRE 10819
9 EXTRACTED XBRL INSTANCE DOCUMENT enfn-20220821x8k_htm.xml XML 5064
Mailing Address 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603
Business Address 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603 (312) 253-9800
Enfusion, Inc. (Filer) CIK: 0001868912 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40949 | Film No.: 221182299
SIC: 7372 Services-Prepackaged Software